In focus · trending topic

Neuralstem

10 stories · following the connections

Neuralstem Added to the Russell Microcap® Index

By Nasdaq OMXJun 26, 2017, 12:32 PM UTC

Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder

By Nasdaq OMXMay 17, 2017, 8:06 PM UTC

Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder

By Nasdaq OMXMay 17, 2017, 8:06 PM UTC

Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update

By Nasdaq OMXMay 10, 2017, 8:07 PM UTC

Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update

By Nasdaq OMXMay 10, 2017, 8:07 PM UTC

Neuralstem to Present at 29th Annual ROTH Conference

By Nasdaq OMXMar 8, 2017, 12:03 PM UTC

Neuralstem Announces Publication of NSI-189 Preclinical Data in Journal of Cellular Physiology

By Nasdaq OMXFeb 28, 2017, 12:03 PM UTC

Neuralstem Announces Issuance of U.S. Patent Covering NSI-189

By Nasdaq OMXFeb 22, 2017, 12:03 PM UTC